Life ScienceCompany
Epirus Biopharmaceuticals M&A Summary
Epirus Biopharmaceuticals has acquired 2 companies. It has also divested 1 asset.
Epirus Biopharmaceuticals’ largest acquisition to date was in 2015, when it acquired Bioceros BV for $14M. It’s largest disclosed sale occurred in 2015, when it sold Zalicus Pharmaceuticals to Taro Pharmaceuticals for $4M. Epirus Biopharmaceuticals has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
Epirus Biopharmaceuticals Business Overview
Where is Epirus Biopharmaceuticals headquartered?
Epirus Biopharmaceuticals is headquartered in Boston, Massachusetts.
How many employees does Epirus Biopharmaceuticals have?
Epirus Biopharmaceuticals has 73 employees.
What sector is Epirus Biopharmaceuticals in?
Epirus Biopharmaceuticals is a life science company.
When was Epirus Biopharmaceuticals founded?
Epirus Biopharmaceuticals was founded in 2011.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 1
- M&A Advisors 2
Unlimited Searches
